Quotient Wealth Partners LLC Has $2.23 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Quotient Wealth Partners LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 3,808 shares of the healthcare conglomerate’s stock after acquiring an additional 274 shares during the period. Quotient Wealth Partners LLC’s holdings in UnitedHealth Group were worth $2,226,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Matrix Trust Co increased its stake in UnitedHealth Group by 1.7% in the third quarter. Matrix Trust Co now owns 3,409 shares of the healthcare conglomerate’s stock valued at $1,993,000 after acquiring an additional 57 shares during the period. UMB Bank n.a. grew its stake in shares of UnitedHealth Group by 12.6% in the 3rd quarter. UMB Bank n.a. now owns 93,391 shares of the healthcare conglomerate’s stock valued at $54,604,000 after purchasing an additional 10,454 shares during the period. Guardian Asset Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $225,000. Advocate Group LLC raised its stake in UnitedHealth Group by 2.5% during the third quarter. Advocate Group LLC now owns 8,094 shares of the healthcare conglomerate’s stock worth $4,732,000 after acquiring an additional 194 shares in the last quarter. Finally, Cypress Wealth Services LLC boosted its stake in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Cypress Wealth Services LLC now owns 1,445 shares of the healthcare conglomerate’s stock valued at $845,000 after purchasing an additional 79 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.9 %

Shares of NYSE:UNH traded up $5.36 during mid-day trading on Thursday, reaching $596.58. The stock had a trading volume of 755,228 shares, compared to its average volume of 3,924,323. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market cap of $550.89 billion, a PE ratio of 36.28, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The firm has a 50 day simple moving average of $582.98 and a two-hundred day simple moving average of $529.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $6.14 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. TD Cowen boosted their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Morgan Stanley increased their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Barclays boosted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. HSBC lifted their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, Robert W. Baird raised their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $614.17.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.